Uniqure CEO discusses company's positive data in hemophilia gene therapy treatment

12:45 PM ET Fri, 16 Nov 2018

Matt Kapusta, CEO of Uniqure, discusses his company soaring on hope for a new hemophilia gene therapy treatment.